Novo Nordisk AS

Forecast & Rating14 analysts currently cover Novo Nordisk AS, with about 21.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $47.23, about 11.0% upside from the current price of $42.53. Price targets range from $39.97 to $64.01 — a wide spread, showing clear disagreement over just how much Novo Nordisk AS can rise. Historically, about 80.7% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Novo Nordisk AS's outlook. Data as of Sep 14, 2026; for reference only and not investment advice.